Literature DB >> 10412704

['Fatigue' in multiple sclerosis].

C Zimmermann1, R Hohlfeld.   

Abstract

Fatigue is a common symptom in patients with multiple sclerosis. Rapid exhaustion and reduced exercise tolerance leads to difficulties in maintaining a normal daily life for many patients. Regular resting and short breaks can help to compensate this to a certain degree. The pathophysiology of fatigue is currently unknown. Damage of specific neuroanatomic regions or a more generalized effect of inflammatory mediators in the central nervous system could be the causes of fatigue. Some drugs (e.g. amantadine) have proven effective in therapy of fatigue. Recent therapeutic approaches have begun using aminopyridines (4-aminopyridine, 3,4-diaminopyridine). These two substances are thought to improve nerve conduction, but there might be a central stimulatory effect as well. Overdosage leads to an elevated risk of epileptic seizures and confusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412704     DOI: 10.1007/s001150050482

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

1.  Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis.

Authors:  David J Hawellek; Joerg F Hipp; Christopher M Lewis; Maurizio Corbetta; Andreas K Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  ["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"].

Authors:  P Flachenecker; G Müller; H König; H Meissner; K V Toyka; P Rieckmann
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

4.  Fatigue, sleepiness, and physical activity in patients with multiple sclerosis.

Authors:  S Merkelbach; H Schulz; H W Kölmel; G Gora; J Klingelhöfer; R Dachsel; F Hoffmann; U Polzer
Journal:  J Neurol       Date:  2010-08-18       Impact factor: 4.849

Review 5.  Management of fatigue in patients with multiple sclerosis.

Authors:  Udo A Zifko
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  [Therapy of day time fatigue in patients with multiple sclerosis].

Authors:  Udo A Zifko
Journal:  Wien Med Wochenschr       Date:  2003

Review 7.  Fatigue in neuroimmunological diseases.

Authors:  Brigitte Greim; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

8.  Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).

Authors:  Brigitte Greim; Reiner Benecke; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 9.  Diagnostics of cognitive dysfunctions in multiple sclerosis.

Authors:  Claudia Engel; Brigitte Greim; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

10.  Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis).

Authors:  Christian Veauthier; Gunnar Gaede; Helena Radbruch; Klaus-Dieter Wernecke; Friedemann Paul
Journal:  Int J Mol Sci       Date:  2015-07-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.